What are the typical levels of Dehydroepiandrosterone sulfate (DHEA-S) in patients with Polycystic Ovary Syndrome (PCOS) and androgen-secreting tumors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DHEA-S Levels in PCOS vs. Androgen-Secreting Tumors

In PCOS, DHEA-S levels are mildly elevated in only 8-33% of patients (typically <600 μg/dL), whereas androgen-secreting tumors typically present with markedly elevated DHEA-S (>600 μg/dL for adrenal tumors) or total testosterone (>250 ng/dL for ovarian tumors), often accompanied by rapid-onset virilization. 1, 2, 3

DHEA-S Levels in PCOS

Prevalence and Magnitude of Elevation

  • Only 8.1-33% of PCOS patients have elevated DHEA-S levels when age-adjusted reference ranges are used, with higher rates (11-33%) in phenotypes A and C (those with clinical/biochemical hyperandrogenism and ovulatory dysfunction). 1, 4

  • The prevalence varies by ethnicity: approximately 20% in White patients and 33% in Black patients with PCOS when adjusted for age and race normative values. 1

  • DHEA-S is NOT a first-line diagnostic marker for PCOS due to poor specificity (67%) compared to total testosterone (86% specificity) or free testosterone (83% specificity). 1, 5

Clinical Significance in PCOS

  • The 2023 International PCOS Guidelines recommend DHEA-S only as a second-line test when total testosterone and free testosterone are not elevated but clinical suspicion remains high. 1

  • DHEA-S levels in PCOS correlate with other androgens (total testosterone r=0.34, androstenedione r=0.24) but show minimal correlation with ovarian markers (AMH, LH, FSH) or metabolic parameters. 4

  • The elevation in PCOS appears related to exaggerated adrenal responsivity to ACTH rather than increased ACTH secretion or altered adrenal sensitivity. 6

Important Caveat

  • Age is critical when interpreting DHEA-S: levels peak between 20-30 years and decline steadily thereafter, so age-adjusted reference ranges must be used to avoid overdiagnosis. 1

DHEA-S Levels in Androgen-Secreting Tumors

Diagnostic Thresholds

  • DHEA-S >600 μg/dL (16.3 μmol/L) raises concern for adrenocortical carcinoma and warrants adrenal imaging with CT scan. 2, 3

  • Total testosterone >250 ng/dL (8.7 nmol/L) suggests ovarian androgen-secreting tumor (such as hilar cell tumor, Sertoli-Leydig cell tumor) and requires transvaginal ultrasound. 2, 3

Clinical Presentation Distinguishing Features

  • Androgen-secreting tumors present with rapid-onset virilization (developing over weeks to months) including: 2, 3

    • Deepening of voice
    • Clitoromegaly
    • Male-pattern baldness
    • Increased muscle mass
    • Breast atrophy

  • PCOS typically presents with gradual onset symptoms (developing over years) including hirsutism, acne, and oligomenorrhea without severe virilization. 1, 2

Diagnostic Performance

  • In a population study of 478 hyperandrogenic patients, only 1 patient (0.2%) had an androgen-secreting tumor, demonstrating the rarity of these neoplasms. 3

  • The positive predictive value of elevated testosterone (>250 ng/dL) for detecting tumors was only 9%, though the negative predictive value was 100%. 3

  • Clinical evaluation alone is often sufficient screening for tumors; routine measurement of DHEA-S and testosterone for tumor screening is not cost-effective given the low prevalence. 3

Practical Diagnostic Algorithm

When to Measure DHEA-S

  1. First-line testing should include total testosterone and free testosterone (by LC-MS/MS or calculated free androgen index), NOT DHEA-S. 1, 2, 5

  2. Measure DHEA-S only if:

    • Total testosterone and free testosterone are normal but clinical suspicion for hyperandrogenism remains high 1
    • Total testosterone is very elevated (>250 ng/dL) to help localize source (adrenal vs. ovarian) 2, 3

  3. Urgent imaging is indicated when:

    • DHEA-S >600 μg/dL → obtain adrenal CT scan 2, 3
    • Total testosterone >250 ng/dL → obtain transvaginal ultrasound 2, 3
    • Rapid virilization regardless of androgen levels → obtain both adrenal CT and pelvic ultrasound 2, 3

Key Pitfall to Avoid

Do not use DHEA-S as a routine screening test for PCOS or for androgen-secreting tumors. The low specificity (67%) leads to unnecessary imaging and anxiety, while clinical features (rapidity of onset, severity of virilization) are more predictive of neoplasms than absolute hormone levels. 1, 3, 4

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Guideline

Hyperandrogenism Diagnosis and Evaluation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3
Research

Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999

4
Research

Is it useful to measure DHEAS levels in PCOS?

Annales d'endocrinologie, 2024

5
Guideline

Diagnostic Workup for Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How to manage Polycystic Ovary Syndrome (PCOS) with elevated Dehydroepiandrosterone (DHEA) levels?
How to manage a patient with elevated DHEAS levels and normal CBC differential?
What is the evaluation and treatment approach for a patient with hyperandrogenism, specifically with elevated DHEA and testosterone levels, suspected of having Polycystic Ovary Syndrome (PCOS)?
Can a young woman have Polycystic Ovary Syndrome (PCOS) with high Dehydroepiandrosterone (DHEA) and normal testosterone levels?
What are the clinical implications and management options for elevated Dehydroepiandrosterone sulfate (DHEAS) levels?
Is Varithena (polidocanol) sclerosant therapy or radiofrequency ablation medically necessary for a patient with bilateral varicose veins?
What oral antibiotics are recommended for treating cellulitis in a patient with a penicillin allergy?
What is the recommended dose of hydrocortisone (cortisol) or other glucocorticoids in acute bronchitis?
Is a staged anterior/posterior operation, including L2-5 anterolateral lumbar fusion via Oblique Lumbar Interbody Fusion (OLIF) approach, L5-S1 Anterior Lumbar Interbody Fusion (ALIF), and L2-S1 posterior lateral fusion, medically indicated for a patient with severe advanced multilevel degenerative changes, spinal listhesis, and significant symptoms, despite being a smoker with a history of falls?
Why was Darvocet (propoxyphene and acetaminophen) discontinued?
What are the typical levels of androstenedione in women with androgen-secreting tumors?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question